DGAP-News: Cytos Biotechnology Ltd announces full year 2010 financial results and major developments in 2010
(firmenpresse) - EquityStory AG-News: Cytos Biotechnology AG / Key word(s): Final
Results
Cytos Biotechnology Ltd announces full year 2010 financial results and
major developments in 2010
17.02.2011 / 07:00
---------------------------------------------------------------------
Schlieren (Zurich), Switzerland, February 17, 2011 - Cytos Biotechnology
Ltd (SIX:CYTN) today presented its full year 2010 financial results and
annual major developments.
The complete press release as well as the Annual Report 2010 can be
downloaded on Cytos Biotechnology's website (www.cytos.com).
End of Corporate News
---------------------------------------------------------------------
17.02.2011 News transmitted by EquityStory AG.
The issuer is responsible for the contents of the release.
EquityStory publishes regulatory releases, media releases on the
capital market and press releases.
The EquityStory Group distributes authentic and real-time financial
news for over 1'300 listed companies.
The Swiss news archive can be found at
http://www.equitystory.ch/nachrichten
---------------------------------------------------------------------
Language: English
Company: Cytos Biotechnology AG
Wagistr. 25
8952 Schlieren
Schweiz
Phone: +41 44 733 4747
Fax: +41 44 733 4740
E-mail: info(at)cytos.com
Internet: www.cytos.com
ISIN: CH0011025217, CH0029060735
Swiss Security Number: -
Listed: Regulierter Markt in SIX; Freiverkehr in
Berlin, München, Stuttgart; Open Market in
Frankfurt
End of News EquityStory AG News-Service
---------------------------------------------------------------------
112483 17.02.2011
Bereitgestellt von Benutzer: EquityStory
Datum: 17.02.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 33227
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 200 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Cytos Biotechnology Ltd announces full year 2010 financial results and major developments in 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
Cytos Biotechnology AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).